Delivery Order SPE2DB20D2002-SPE2DB23FL50S

Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $131
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $375,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. Under this contract, Amerisourcebergen will provide approximately 3,750 insulin lispro pens to support the Department of Defense's medical supply needs. The place of performance is the contractor's facility in Conshohocken, Pennsylvania. The period of performance is September 13-14, 2023. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $72,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. Under this order, Amerisourcebergen will provide 3mL insulin lispro pens to support the Department of Defense's medical supply needs. The delivery location is Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance is required from July 24-25, 2023. No subcontractors or set aside designations were specified. This order was placed...
The Defense Logistics Agency awarded a $44,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro injectable medication. The contract calls for Amerisourcebergen to provide 10 milliliter vials containing 100 units per milliliter of insulin lispro for distribution to DLA locations from a place of performance in Conshohocken, Pennsylvania. No set aside designation or subcontractors were identified. This supports DLA's mission to provide medical supplies to...
The Defense Logistics Agency awarded a $265,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro. The order is for 10 milliliter vials of the drug to support Defense Department health programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the Department of Defense's global...
The Defense Logistics Agency awarded a $154,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 unit/mL vials of insulin lispro. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 10 mL vials of the prescribed medication to a facility in Conshohocken, Pennsylvania by July 3, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this...
The Defense Logistics Agency awarded a $464 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. As part of its mission to support military readiness through logistics solutions, the DLA procured 3mL insulin lispro pens from Amerisourcebergen's Conshohocken, Pennsylvania location for delivery between July 10-11, 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will fulfill the order without involvement of major...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $309.24 to Amerisourcebergen Drug Corp for the supply of 100 unit/ml pens of insulin lispro in 3ml quantities. As a prime contractor to DLA, Amerisourcebergen will deliver the requested pharmaceutical products under the terms of the order from June 26-27, 2023. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified in...
The Defense Logistics Agency awarded a $43,760 delivery order to Amerisourcebergen Drug Corporation for insulin lispro. The firm fixed price order is for delivery of 10 milliliter vials containing 100 units per milliliter of the drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 13 to July 14, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support...
The Defense Logistics Agency awarded a $36,460 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. Under this order, Amerisourcebergen will provide 3mL insulin lispro pens to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on August 28, 2023. No set-aside designation or subcontractors were identified. The Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-six thousand four hundred sixty dollars to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. Under the contract, Amerisourcebergen will deliver one hundred unit per milliliter insulin lispro pens packaged in three milliliter cartridges to an address in Conshohocken, Pennsylvania. Performance is required from August twenty-eight through August twenty-nine of twenty twenty-three. As a major...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB23FL50S
    Delivery Order

The Defense Logistics Agency awarded a $131,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro injectable medication. The prime contractor will provide approximately 10,000 units of the drug to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. No subcontractors or set aside designations were specified. This order is likely part of DLA's portfolio for procuring pharmaceuticals and medical supplies on behalf of the Military Health System and other DoD components.

Generated 12/24/23, 12:21 AM